Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

BioMarin Adds Board Member

This article was originally published in Scrip

Executive Summary

BioMarin Pharmaceutical Inc. has appointed former chair and CEO of Allergan, David Pyott, to its board of directors. Pyott was CEO of Allergan from 1998 to 2015 and was recognized by the Harvard Business Review as one of 'The 100 Best Performing CEOs in the World'. Prior to Allergan he was the head of Novartis nutrition division and a member of the executive committee of Novartis AG. Currently Pyott is lead director and board member of Avery Dennison Corporation and a board member of Alnylam Pharmaceuticals Inc.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst